Our Pricing

Buy Slimming Injections Online UK - Side Effects Info

Published on: June 03, 2026

When you buy slimming injections online UK, understanding potential side effects is essential for safe, effective treatment. At Cured Pharmacy, our UK-registered clinical team provides transparent information about prescription weight loss injections, including Mounjaro, Wegovy, and Saxenda, alongside comprehensive medical assessment to ensure suitability.

How Prescription Slimming Injections Work in the UK

Prescription slimming injections available in the UK are GLP-1 receptor agonists, a class of medications originally developed for type 2 diabetes but now licensed by the MHRA for weight management [1]. These treatments mimic natural hormones that regulate appetite, slow gastric emptying, and enhance feelings of fullness after meals.

Mounjaro (tirzepatide) represents the latest advancement, acting on both GIP and GLP-1 receptors simultaneously. In the SURPASS-2 trial, participants achieved an average weight reduction of 22.5% over 72 weeks at the highest dose — significantly greater than single-pathway alternatives [1]. Wegovy (semaglutide) and Saxenda (liraglutide) work through GLP-1 pathways alone, with clinical trials demonstrating average weight reductions of 14.9% and 8% respectively [2][3].

All prescription slimming injections require clinical assessment by a UK prescriber before dispensing. At Cured Pharmacy, our free online consultation takes under three minutes, with prescriptions reviewed by GPhC-registered clinicians including our superintendent pharmacist Tarun Kumar (GPhC 2233073).

Common Side Effects of Slimming Injections

Understanding side effects helps you make informed decisions when you buy slimming injections online UK. The most frequently reported side effects are gastrointestinal, affecting approximately 30-50% of patients during initial treatment phases [1][2].

Nausea is the most common side effect, typically occurring when starting treatment or increasing doses. In clinical trials, 20-44% of patients reported nausea, though symptoms usually diminish within 4-8 weeks as the body adjusts [2]. Other common gastrointestinal effects include diarrhoea (reported by 21-30% of patients), constipation (11-24%), and occasional vomiting (5-9%) [1][3].

These side effects are generally mild to moderate in severity. UK prescribers recommend starting at the lowest dose and gradually increasing over several weeks to minimise gastrointestinal symptoms. Staying well-hydrated, eating smaller meals, and avoiding high-fat foods can help manage these effects during the adjustment period.

Managing Gastrointestinal Side Effects

Most patients find that nausea and digestive symptoms improve significantly after the first month of treatment. Practical strategies include taking your injection on the same day each week, eating slowly, avoiding lying down immediately after meals, and choosing bland, easily digestible foods during the initial weeks. If symptoms persist or worsen, contact your prescriber — dose adjustments may be appropriate.

Serious Side Effects and When to Seek Medical Attention

While most side effects are manageable, certain symptoms require immediate medical attention. Severe abdominal pain, particularly if accompanied by nausea and vomiting, may indicate pancreatitis — a rare but serious condition reported in approximately 0.2% of patients in clinical trials [1][4].

Signs of thyroid tumours, though extremely rare in humans, warrant monitoring. In animal studies, tirzepatide and semaglutide were associated with thyroid C-cell tumours, leading to contraindications for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [1][2]. Report any persistent hoarseness, difficulty swallowing, or neck lumps to your healthcare provider immediately.

Gallbladder problems occur more frequently with rapid weight loss. Symptoms include severe upper right abdominal pain, fever, and yellowing of skin or eyes. Clinical trials showed gallbladder-related adverse events in 1.5-2.7% of patients taking GLP-1 treatments [3][4]. Allergic reactions, though uncommon, require emergency care if you experience facial swelling, difficulty breathing, or severe rash.

Contraindications and Patient Suitability

Slimming injections are not suitable for everyone. Contraindications include pregnancy or breastfeeding, personal or family history of medullary thyroid carcinoma, history of pancreatitis, severe gastrointestinal disease, and type 1 diabetes. Your UK prescriber will assess your complete medical history during consultation to ensure treatment safety and appropriateness.

Comparing Side Effect Profiles: Mounjaro, Wegovy, and Saxenda

Each prescription slimming injection has a distinct side effect profile based on its mechanism and dosing schedule. Mounjaro's dual-agonist action produces slightly higher rates of gastrointestinal side effects initially — nausea affected 33-38% of patients in SURPASS trials compared to 24-32% with Wegovy in STEP trials [1][2].

Saxenda, administered daily rather than weekly, may cause more frequent but milder nausea episodes. Approximately 39% of patients reported nausea in clinical trials, though the daily dosing allows for more gradual titration [3]. Weekly injections like Mounjaro and Wegovy provide more stable hormone levels throughout the week, which some patients find easier to tolerate.

Injection site reactions — redness, itching, or mild swelling — occur in 2-5% of patients across all three treatments. These are typically mild and resolve within 24-48 hours. Rotating injection sites (abdomen, thigh, upper arm) reduces the likelihood of persistent irritation.

Long-Term Safety and Monitoring Requirements

Long-term safety data for GLP-1 receptor agonists extends beyond five years, with ongoing monitoring by the MHRA and international regulatory bodies. Cardiovascular outcome trials have demonstrated safety and potential benefits, with semaglutide showing a 26% reduction in major adverse cardiovascular events in patients with established cardiovascular disease [5].

Regular monitoring during treatment includes blood glucose levels (particularly if you have prediabetes), kidney function, and weight loss progress. UK prescribers typically recommend follow-up consultations every 3-6 months to assess treatment efficacy and side effect management. At Cured Pharmacy, our clinical team provides ongoing support throughout your treatment journey.

Bone health deserves attention during significant weight loss. While GLP-1 treatments themselves don't directly affect bone density, rapid weight reduction can impact calcium absorption. Ensuring adequate calcium and vitamin D intake, alongside weight-bearing exercise, supports bone health during treatment [4].

What Happens When You Stop Treatment

Discontinuing slimming injections typically results in gradual return of appetite and potential weight regain. Clinical studies show that approximately 60-70% of lost weight may return within 12 months of stopping treatment [2]. This highlights the importance of establishing sustainable lifestyle changes during treatment. Your prescriber will discuss long-term weight maintenance strategies, including dietary modifications and physical activity programmes, to optimise lasting results.

Buying Slimming Injections Safely Online in the UK

When you buy slimming injections online UK, verification of pharmacy credentials protects your health and ensures genuine medications. Cured Pharmacy is registered with the General Pharmaceutical Council (GPhC Registration Number 9012511), guaranteeing compliance with UK pharmaceutical regulations and dispensing standards.

Legitimate UK online pharmacies require clinical assessment before prescribing weight loss injections — any website offering these medications without consultation operates illegally and may supply counterfeit products. Our free online assessment takes under three minutes and is reviewed by UK-registered prescribers who determine suitability based on your medical history, current medications, and weight loss goals.

Transparent pricing distinguishes reputable pharmacies from misleading competitors. At Cured Pharmacy, you see exact prices before consultation: Mounjaro from £135.00, Wegovy from £135.00, and Saxenda from £135.00. We guarantee the lowest prices in the UK with 100% discreet packaging and genuine UK-licensed medicines only. All treatments are dispatched from our UK pharmacy with tracked delivery, ensuring your medication arrives safely and confidentially.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). GLP-1 Receptor Agonists: Reports of Diabetic Ketoacidosis When Concomitant Insulin Was Rapidly Decreased or Discontinued. Drug Safety Update, 16(9), A1. [accessed 13 August 2026]
5. Marso, S. P., Bain, S. C., Consoli, A., et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine, 375(19), 1834–1844. https://doi.org/10.1056/NEJMoa1607141 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Side effect frequencies are based on clinical trial data and individual experiences may vary.